Browsing by Author "Rockhold, FW"
Now showing items 1-6 of 6
-
Cellular Electrophysiology of Clofilium, a New Antifibrillatory Agent, in Normal and Ischemic Canine Purkinje Fibers
Steinberg, MI; Sullivan, ME; Wiest, SA; Rockhold, FW; Molloy, BB (Journal of Cardiovascular Pharmacology, 1981-07) -
Continuous intravenous cimetidine decreases stress-related upper gastrointestinal hemorrhage without promoting pneumonia.
Martin, LF; Booth, FV; Karlstadt, RG; Silverstein, JH; Jacobs, DM; Hampsey, J; Bowman, SC; ... (9 authors) (Crit Care Med, 1993-01)OBJECTIVES: To determine whether a continuous i.v. infusion of cimetidine, a histamine-2 (H2) receptor antagonist, is needed to prevent upper gastrointestinal (GI) hemorrhage when compared with placebo and if that usage ... -
Data monitoring and interim analyses in the pharmaceutical industry: ethical and logistical considerations.
Rockhold, FW; Enas, GG (Stat Med, 1993-03)The characteristics of data monitoring and the need for the use of data monitoring committees in clinical trials sponsored by the pharmaceutical industry differ from those of trials sponsored by government. Data monitoring ... -
Methods of Discrimination Among Stochastic Models of the Negative Binomial Distribution with an Application to Medical Statistics
Rockhold, FW; Kilpatrick, SJ (Biometrical Journal, 1981) -
Statistical controversies in clinical research: data access and sharing-can we be more transparent about clinical research? Let's do what's right for patients.
Rockhold, FW (Ann Oncol, 2017-08-01)Calls for greater transparency and 'open data access' in clinical research are widespread, from sources including the Executive Office of the President, which in 2013 called for increased access to the results of federally ... -
Strategic use of statistical thinking in drug development.
Rockhold, FW (Stat Med, 2000-12-15)The role of the statistician and statistical thinking in the pharmaceutical industry has evolved greatly in the last four or five decades. Regulatory developments and the changing face of the science of drug development ...